Skip links
Companies
› United States › CELLDEX THERAPEUTICS, INC.
Company registry profile
CELLDEX THERAPEUTICS, INC. logo

CELLDEX THERAPEUTICS, INC.

Active

From the registry

Registration details

Registration No.
F15000002505
Incorporation Date
2015-06-05
Company Type
Not disclosed
Address
HAMPTON, United States
Website
www.celldex.com/
Status
Active
Country
United States
Source: Florida Department of State — SunbizRegistry coverage
Registry summary

Company overview

CELLDEX THERAPEUTICS, INC. is a registered legal entity registered in United States under F15000002505, and its current status with Florida Department of State — Sunbiz is active. The company was incorporated on 5 June 2015 and lists its registered address as HAMPTON, United States. 5 shareholders are on record for CELLDEX THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn.

Data Provenance
This record is sourced directly from official government registries, including Florida Department of State — Sunbiz.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

5

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Vanguard Group Inc 7.1% Florida Department of State — Sunbiz
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF 3.4% Florida Department of State — Sunbiz
iShares Trust-iShares Russell 2000 ETF 2.9% Florida Department of State — Sunbiz

Registry notes and limitations

Five shareholders are currently on record for CELLDEX THERAPEUTICS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Vanguard Group Inc, holding 7.1% — the largest recorded stake — followed by SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF at 3.4%; the remaining 3 shareholders shown hold smaller stakes.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Officers

5

EC
ELIZABETH CROWLEY ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Product Development Officer & Senior Vp

AM
ANTHONY MARUCCI ACTIVE

Residence
🇺🇸 United States
Occupation
Governor

SC
SARAH CAVANAUGH ACTIVE

Residence
🇺🇸 United States
Occupation
Governor

TK
TIBOR KELER ACTIVE

Residence
🇺🇸 United States
Occupation
Governor

MH
MARGO HEATH-CHIOZZI ACTIVE

Residence
🇺🇸 United States
Occupation
Governor

Registry notes and limitations

The Chief Product Development Officer & Senior Vp of CELLDEX THERAPEUTICS, INC. currently on record is ELIZABETH CROWLEY; five officers are currently on record for CELLDEX THERAPEUTICS, INC., filed with Florida Department of State — Sunbiz.

The register reports 28 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at CELLDEX THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Group Structure

Top of recorded group
CELLDEX THERAPEUTICS, INC.
United States
Celldex Research Corporation
United StatesUS NJ 0100904519

Kolltan Pharmaceuticals, Inc.
United StatesUS 4459438

Xetrios Therapeutics, Inc.
United StatesUS CA 4756073

Curagen Corporation
United StatesUS MA 2279847

Celldex Therapeutics Switzerland GmbH
SwitzerlandCH CHE-151.632.228

How these relationships were recorded

CELLDEX THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 5 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 5 subsidiaries span United States, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Registry questions

Frequently asked questions

Who owns CELLDEX THERAPEUTICS, INC.?

Five shareholders are currently on record for CELLDEX THERAPEUTICS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 7.1% — the largest recorded stake — followed by SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF at 3.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is CELLDEX THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for CELLDEX THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does CELLDEX THERAPEUTICS, INC. have on record?

5 shareholders are shown on record for CELLDEX THERAPEUTICS, INC..

What is CELLDEX THERAPEUTICS, INC.'s company registration number?

CELLDEX THERAPEUTICS, INC.'s registration number is F15000002505, filed with Florida Department of State — Sunbiz in United States. Its current status on the register is active.

Is CELLDEX THERAPEUTICS, INC. still an active company?

CELLDEX THERAPEUTICS, INC.'s status on Florida Department of State — Sunbiz is listed as active.

When was CELLDEX THERAPEUTICS, INC. incorporated?

CELLDEX THERAPEUTICS, INC. was incorporated on 5 June 2015, according to Florida Department of State — Sunbiz.

What is CELLDEX THERAPEUTICS, INC.'s registered address?

The registered address on file for CELLDEX THERAPEUTICS, INC. is HAMPTON, United States.

Who are the officers/directors of CELLDEX THERAPEUTICS, INC.?

The Chief Product Development Officer & Senior Vp of CELLDEX THERAPEUTICS, INC. currently on record is ELIZABETH CROWLEY; five officers are currently on record for CELLDEX THERAPEUTICS, INC., filed with Florida Department of State — Sunbiz. Management authority at CELLDEX THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does CELLDEX THERAPEUTICS, INC. have a parent company or subsidiaries?

CELLDEX THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 5 subsidiaries recorded beneath it across 2 jurisdictions. Those 5 subsidiaries span United States, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

This website uses cookies to improve your web experience.